Overexpression of PGC-1α significantly improves neurological function in HD-model transgenic mice by reducing htt protein aggregation and oxidative stress. This discovery may lead to therapies targeting PGC-1α function for treating Huntington's disease and related disorders.
Scientists at IRB Barcelona have identified a new protein crucial for mitochondrial function in the fruit fly Drosophila melanogaster. The removal of this protein leads to aberrant mitochondria and metabolic capacity loss, causing death.
Researchers found that damaged mitochondria in the brain's neurons can lead to impaired synapses, crucial for normal brain function. Modifying cyclosporin, a drug already approved for organ transplant patients, may help slow down Alzheimer's disease at its earliest stages.
A study reveals that mutant SOD1 interacts with VDAC1, disrupting its function and leading to mitochondrial damage and motor neuron degeneration. Reduced VDAC1 activity accelerates the onset of fatal paralysis in ALS mice.
Scientists at EMBL have identified IRPs as key proteins ensuring iron balance in cells. In a study, they found that IRPs are required for mitochondrial function and that their dysfunction leads to iron deficiency and cellular damage.
Researchers at the University of Florida found that anti-aging supplement mixtures may be more effective in preventing decline in physical function than single compounds. Taking such supplements before very old age can lead to improved grip strength and mitochondrial function, suggesting a potential window for intervention.
A low protein diet boosts mitochondrial function, extending lifespan in flies. This discovery has implications for human aging and diseases such as obesity, diabetes, and cancer.
Parkinson-associated genes PINK1 and Parkin functionally interact to maintain mitochondrial function, impairing neuron loss
A recent study published in Science found that the STAT3 protein plays a key role in converting normal cells to cancerous cells by regulating gene expression in both the cell nucleus and mitochondria. This discovery may lead to the development of targeted cancer therapies.
Scientists identified a protein that regulates mitochondrial movement in brain cells, shedding light on how the brain recovers from stroke. Understanding this mechanism may help identify novel approaches for preventing and treating neurological disorders.
Researchers have developed a mouse model of Wolfram Syndrome, linking CISD2 gene function to mitochondrial integrity and aging. CISD2-deficient mice display premature aging, decreased body weight, and degeneration of optic and muscular tissues.
Researchers discovered that PARL plays a key role in initiating apoptosis in mitochondria, leading to faster cell death and increased risk of diseases like Parkinson's. The study used 'knock-out' mice that lacked PARL, showing that the protein is essential for protecting cells from controlled cell death.
Researchers found substances increasing mitochondrial size also boost cardiac contractility. This effect isn't related to energy production; instead, it suggests a form of mechanical signaling between organelles in cardiac cells. The study opens possibilities for developing drugs that enhance heart function.
Researchers discover that excessive amyloid-beta toxicity leads to functional heme deficiency, causing mitochondrial decay and oxidative damage. A new class of targeted drugs could soon be developed to address this underlying mechanism.
The Entamoeba mitosome, a human parasite's organelle, contains a single type of protein that imports and exports chemicals. This streamlined organelle may represent the simplest mitochondrion yet described, offering insights into eukaryotic cell function.
A national clinical trial with 80 Parkinson's patients showed that high-dose coenzyme Q10 slowed functional decline by 44%, particularly in everyday activities. The therapy needs to be tested in a larger trial before it can be recommended.
A combination of two compounds, acetyl-l-carnitine and alpha-lipoic acid, have been shown to improve physical and mental function in older rats. The study suggests that these compounds may have therapeutic potential for humans, with the goal of improving quality of life and health.